About: Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision therapies to treat solid tumors. The company's proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates. Its lead candidate is bel-sar, which is in late-stage clinical development for the treatment of patients with primary choroidal melanoma and other ocular oncology indications, as well as in early-stage clinical development in bladder cancer. It focuses on assessing the safety and efficacy of bel-sar in treating a range of other solid tumors, including bladder cancer. The company was incorporated in 2009 and is headquartered in Boston, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $6.30 (-1.64%)
AURA NASDAQ Aura Biosciences Inc
Aura Biosciences Inc share price
Atividade de preço de AURA
Último preço
$ 6,330
Variação (24h)
-0,07 USD (1,09%)
Volume
769.93K
Volume (média 4 sem.)
-
Abertura
$ 6,46
Variação do dia
$ 6,26 - $ 6,51
Fechamento anterior
$ 6,40
Último negócio
29 Oct, 8:01 pm GMT+0
Atrasado
29 Oct, 8:01 pm GMT+0
AURA price performance
Atrasado
29 Oct, 8:01 pm GMT+0
quote.marketSignals